Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome

por Moreira, Wilfried, Santhanakrishnan, Sridhar, Ngan, Grace J. Y., Low, Choon Bing, Sangthongpitag, Kanda, Poulsen, Anders, Dymock, Brian W., Dick, Thomas
Publicado 2017

Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors

por Choong, Meng Ling, Pecquet, Christian, Pendharkar, Vishal, Diaconu, Carmen C, Yong, Jacklyn Wei Yan, Tai, Shi Jing, Wang, Si Fang, Defour, Jean-Philippe, Sangthongpitag, Kanda, Villeval, Jean-Luc, Vainchenker, William, Constantinescu, Stefan N, Lee, May Ann
Publicado 2013